Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD

By sjmartinez • February 13, 2025

Sciurba FC, Christenson SA, Rheault T, Bengtsson T, Rickard K, Barjaktarevic IZ. Effect of Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine on Exacerbation Rate and Risk in Patients With Moderate to Severe COPD. Chest. 2025 Feb;167(2):425-435. doi: 10.1016/j.chest.2024.07.168. Epub 2024 Aug 27. PMID: 39197510.

Tags: COPD, ensifentrine, exacerbation, patient-reported outcomes, Publications, Pulmonary, Critical Care & Sleep Medicine

Predicting Oral HIV Pre-Exposure Prophylaxis Efficacy in Cisgender Women Across Pregnancy and Postpartum

Yu Y, Brooks KM, Doncel GF, Best BM, Marzinke MA, Mirochnick M, Anderson PL, Myer L, Celum C, Heffron R, Coleman J, Davey DLJ, Zhang[...]

Association between Alzheimer’s disease-related genes and neurodegenerative blood-based biomarkers in Indian adults

Abu-Amara H, Zhao W, Li Z, Leung YY, Schellenberg GD, Wang LS, Crimmins EM, Thyagarajan B, Anwar M, Hu P, Dey S, Dey AB, Zhou[...]

Metastatic Melanoma Presenting As Small Bowel Obstruction

Ruci A, Chan SM, Kan CK, Fagel C, Maque J. Metastatic Melanoma Presenting As Small Bowel Obstruction. Cureus. 2026 Aug 2;18(8):e113827. doi: 10.7759/cureus.113827. PMID: 42688324;[...]